Three-member team to tackle problems at India's drug regulator
This article was originally published in SRA
Executive Summary
The Indian government has set up a three-member committee to come up with measures that will bring about systemic and other improvements at the Central Drugs Standard Control Organization following a damning parliamentary committee report on regulatory lapses in approving new drugs1,2.